Health & pharmaceuticals news

Latest breaking stories, features and analysis

UnitedHealth’s revenue jumps 7.5% in the fiscal fourth quarter
  • UnitedHealth’s revenue jumps 7.5% in the fiscal fourth quarter.
  • The health care company reports £1.62 billion of net income.
  • UnitedHealth expects £12.99 to £13.35 of full-year adjusted EPS.
January 20, 2021
AstraZeneca wins approval for its COVID-19 vaccine in Pakistan and Brazil
January 18, 2021
Bluebird Bio CEO talks business spinoff after a 47% loss in 2020
January 12, 2021

Trending news

Market analysis

AstraZeneca stock price gains as Trump considers fast-tracking their COVID-19 vaccine
Shares of AstraZeneca PLC (LON: AZN) gained over 1% on reports that the U.S. government considers fast-tracking the approval for Astrazeneca’s coronavirus vaccine in the States before the forthcoming presidential elections, according to a report by the Financial Times.  Fundamental analysis: Unrealistic scenario? The FT report said that…
August 25, 2020
Bayer stock price slips after reporting a Q2 loss of $11.2 billion
Shares of Bayer AG (ETR: BAYN) slipped 4% after the German pharma giant reported a big loss in the second quarter of the year. Bayer stock price is now trading near 3-months lows.  Fundamental analysis: Roundup costs push Bayer to a loss Bayer, the German pharmaceutical and chemicals giant,…
August 4, 2020
Relief Therapeutics’ stock price explodes 90% on emergency COVID-19 treatment
Shares of Relief Therapeutics (SIX: RLF) exploded 80% on Monday after the drugmaker said its “RLF-100” treatment, developed together with the U.S.-Israeli firm NeuroRx, showed early potential. Fundamental analysis: Emergency treatment for critically ill patients NeuroRx and Relief, a Swiss-based drugmaker, issued a joint statement to note progress with…
August 3, 2020
Sanofi stock price moves higher on a £500 million vaccine deal
Shares of Sanofi (EPA: SAN) gained around 1% today after the UK government agreed to buy $500 million worth of COVID-19 vaccines from Sanofi and GlaxoSmithKline (LON: GLK). Moreover, the French giant raised its 2020 earnings forecast today.  Fundamental analysis: Earnings forecast upgraded  Sanofi, the world’s fifth-largest pharma…
July 29, 2020

More breaking stories

UK’s MHRA approves Moderna’s COVID-19 vaccine for emergency use
Walgreens says pharmacy sales remained strong in the fiscal first quarter
Walgreens to sell its distribution unit to AmerisourceBergen for £4.78 billion
UnitedHealth to acquire Change Healthcare for £5.78 billion
AstraZeneca completes sale of commercial rights to Atacand for £294 million
Analyst talks Biotech sector, offers three picks for 2021
Britain becomes the first country to approve AstraZeneca’s COVID-19 vaccine
Pfizer to deliver 100 million additional doses of its COVID-19 vaccine to the U.S. government
Eli Lilly to acquire gene therapy specialist Prevail Therapeutics for £770 million
AstraZeneca to acquire Alexion Pharmaceuticals for £29.50 billion
Pfizer’s COVID-19 vaccine wins emergency use authorisation from the U.S. FDA
Report: Coronavirus vaccines are being shipped right now
Benchmark’s revenue slides to £25.2 million in fiscal Q4
AstraZeneca to launch a new global trial for its COVID-19 vaccine
AstraZeneca says its COVID-19 vaccine has an efficacy of 70% on average
Pharmacy Stocks Under Pressure 8% after Amazon’s new pharmacy push
Moderna says its COVID-19 vaccine is effective in over 94% of the cases
Pfizer/BioNTech COVID-19 vaccine is effective in more than 90% of cases
CVS Health Corp tops analysts’ estimates for earnings and revenue in fiscal Q3
AstraZeneca says net profit jumped more than 100% in the third quarter
Bayer AG swings to a net loss of £2.46 billion in the fiscal third quarter
Humana says its revenue was 23.6% higher in the fiscal third quarter
1 2 3 4 5 6 7 8 9 … 58

Other topics

Alternative Investment
Bonds
Commodities
Cryptocurrency
Forex
Market analysis
Personal finance
Real estate
Stocks & shares
World